Quantcast
Last updated on April 17, 2014 at 11:49 EDT

AlloSource Launches AlloMend(TM): Allograft Offers New Possibilities in Soft Tissue Repair

August 15, 2013

AlloMend, the latest innovation from AlloSource, maximizes the gift of tissue donation

CENTENNIAL, Colo., Aug. 15, 2013 /PRNewswire-USNewswire/ — AlloSource (allosource.org), one of the nation’s largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world’s largest processor of cellular bone allografts, today announced the launch of a new proprietary allograft, AlloMend Acellular Dermal Matrix (ADM). The new allograft can be used in a broad range of soft tissue surgical procedures, including ventral hernia repair and post-mastectomy reconstruction.

AlloMend ADM is created through a proprietary process in which viable cellular elements that are capable of triggering an immune response are removed from donated human skin, leaving a collagen elastin matrix behind. Upon transplantation, the recipient’s own cells infiltrate and repopulate this three-dimensional scaffold to begin the revascularization and remodeling process.

“We are dedicated to finding new ways to maximize the gift of life from generous tissue donors and courageous donor families,” said Thomas Cycyota, AlloSource president and CEO. “AlloMend is the latest allograft in a history of progressive innovations from AlloSource, and we look forward to it bringing the benefits of regenerative medicine to more patients in need.”

AlloMend ADM is processed with an exclusive tissue cleansing process without the use of detergents or enzymes. Therefore, no harmful residuals are left in the tissue. Additionally, studies show that AlloMend exceeds the tensile strength – the measure of force needed to break a biomaterial – of the leading acellular dermal matrices. As a result, AlloMend is strong while remaining flexible and pliable, offering maximum assurance in surgical tissue repair surgeries.

By focusing on quality, safety, service and a commitment to its mission, AlloSource has grown into one of the nations’ largest and most respected tissue banks. The Company’s safety and tissue processing standards meet the guidelines set forth by the FDA and the American Association of Tissue Banks.

About AlloSource
AlloSource is a non-profit company that offers more than 200 types of precise bone, skin, soft-tissue and custom-machined allografts for use in an array of life-saving and life-enhancing medical procedures. As the world’s leader in fresh cartilage tissue used for joint repair and skin allografts to heal severe burns, AlloSource has grown into one of the largest tissue networks in the country with more than 400 employees. It is the world’s largest processor of cellular bone allografts and delivers unparalleled expertise and customer service to its growing network of surgeons, partners and the country’s most reputable organ procurement organizations. As one of the leading innovators in maximizing tissue donation with the goal of offering optimal solutions for healthcare providers and their patients, AlloSource is recognized by the medical community for its ability to process and provide high quality tissue. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO. For more information, please visit allosource.org or our educational website, allograftpossibilities.org.

Media Contact
Colleen Kilkenny
AlloSource
720. 382. 2756
ckilkenny@allosource.org

SOURCE AlloSource


Source: PR Newswire